Céphalées pharmacorésistantes: nouvelles approches du casse-tête [Drug-resistant headache: is it the end?].


Autoria(s): Nater B.; Dozier C.
Data(s)

2012

Resumo

Chronic primary headache often cause significant interference with function and quality of life despite acute and preventive medicines. New treatments are emerging for pharmacologically intractable cluster headache and migraine. Occipital nerve stimulation in chronic cluster headache and botulinum toxin in chronic migraine represent the most promising therapies.

Identificador

http://serval.unil.ch/?id=serval:BIB_A75670D36480

isbn:1660-9379 (Print)

pmid:22675824

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 8, no. 339, pp. 937-941

Palavras-Chave #Analgesics/therapeutic use; Cluster Headache/etiology; Cluster Headache/therapy; Drug Resistance/physiology; Headache/drug therapy; Headache Disorders/drug therapy; Humans; Migraine Disorders/etiology; Migraine Disorders/therapy; Neurology/methods; Neurology/trends
Tipo

info:eu-repo/semantics/review

article